Veriskin Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Series 1
- Investors
-
13
Veriskin General Information
Description
Developer of a handheld device designed to offer non-invasive skin cancer diagnosis. The company's device determines if a suspect skin growth is cancerous and also provides a non-subjective assessment of suspect skin regions by non-specialist frontline caregivers, enabling caregivers to detect cancer in patients at an early and treatable stage.
Contact Information
Website
www.veriskin.comCorporate Office
- 10211 Pacific Mesa Boulevard
- Suite 404
- San Diego, CA 92121
- United States
Corporate Office
- 10211 Pacific Mesa Boulevard
- Suite 404
- San Diego, CA 92121
- United States
Veriskin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Seed Round | 10-Nov-2022 | Completed | Generating Revenue | |||
| 7. Grant | 22-Sep-2021 | Completed | Generating Revenue | |||
| 6. Seed Round | 09-Nov-2020 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 28-May-2020 | Completed | Generating Revenue | |||
| 4. Grant | 15-Mar-2020 | Completed | Generating Revenue | |||
| 3. Grant | 01-Mar-2020 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 13-Apr-2017 | Completed | Generating Revenue | |||
| 1. Grant | 01-May-2016 | $1.88M | Completed | Startup |
Veriskin Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Veriskin Patents
Veriskin Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180146866-A1 | Cutaneous blood flow monitoring device | Inactive | 15-May-2015 | ||
| WO-2016187136-A1 | Cutaneous blood flow monitoring device | Inactive | 15-May-2015 | ||
| AU-2014360173-A1 | Skin perfusion monitoring device | Active | 05-Dec-2013 | ||
| AU-2014360173-B2 | Skin perfusion monitoring device | Active | 05-Dec-2013 | ||
| CA-2965866-A1 | Skin perfusion monitoring device | Active | 05-Dec-2013 | A61B5/0261 |
Veriskin Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Anvaya Ventures | Venture Capital | Minority | ||
| Ariel Savannah Angel Partners | Angel Group | Minority | ||
| Arizona Tech Investors | Angel Group | Minority | ||
| Digilife | Venture Capital | Minority | ||
| Frontier Angels | Angel Group | Minority |
Veriskin FAQs
-
When was Veriskin founded?
Veriskin was founded in 2013.
-
Where is Veriskin headquartered?
Veriskin is headquartered in San Diego, CA.
-
What industry is Veriskin in?
Veriskin’s primary industry is Diagnostic Equipment.
-
Is Veriskin a private or public company?
Veriskin is a Private company.
-
What is Veriskin’s current revenue?
The current revenue for Veriskin is .
-
How much funding has Veriskin raised over time?
Veriskin has raised $682K.
-
Who are Veriskin’s investors?
Anvaya Ventures, Ariel Savannah Angel Partners, Arizona Tech Investors, Digilife, and Frontier Angels are 5 of 13 investors who have invested in Veriskin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process